Logo image of GRA.CA

NANOXPLORE INC (GRA.CA) Stock Fundamental Analysis

TSX:GRA - Toronto Stock Exchange - CA63010G1000 - Common Stock - Currency: CAD

2.355  -0.02 (-0.63%)

Fundamental Rating

3

GRA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 28 industry peers in the Chemicals industry. The financial health of GRA is average, but there are quite some concerns on its profitability. While showing a medium growth rate, GRA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year GRA has reported negative net income.
GRA had a positive operating cash flow in the past year.
In the past 5 years GRA always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: GRA reported negative operating cash flow in multiple years.
GRA.CA Yearly Net Income VS EBIT VS OCF VS FCFGRA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

GRA has a Return On Assets (-6.48%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -9.69%, GRA is in the better half of the industry, outperforming 60.71% of the companies in the same industry.
Industry RankSector Rank
ROA -6.48%
ROE -9.69%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GRA.CA Yearly ROA, ROE, ROICGRA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40 -50

1.3 Margins

GRA's Gross Margin of 18.57% is in line compared to the rest of the industry. GRA outperforms 46.43% of its industry peers.
GRA's Gross Margin has improved in the last couple of years.
GRA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y46.47%
GM growth 5Y4.81%
GRA.CA Yearly Profit, Operating, Gross MarginsGRA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

4

2. Health

2.1 Basic Checks

GRA does not have a ROIC to compare to the WACC, probably because it is not profitable.
GRA has more shares outstanding than it did 5 years ago.
GRA.CA Yearly Shares OutstandingGRA.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2024 50M 100M 150M
GRA.CA Yearly Total Debt VS Total AssetsGRA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2024 50M 100M 150M

2.2 Solvency

GRA has an Altman-Z score of 5.05. This indicates that GRA is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of GRA (5.05) is better than 78.57% of its industry peers.
A Debt/Equity ratio of 0.14 indicates that GRA is not too dependend on debt financing.
GRA has a Debt to Equity ratio of 0.14. This is amongst the best in the industry. GRA outperforms 82.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 5.05
ROIC/WACCN/A
WACC7.85%
GRA.CA Yearly LT Debt VS Equity VS FCFGRA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 1.99 indicates that GRA should not have too much problems paying its short term obligations.
GRA has a Current ratio of 1.99. This is in the better half of the industry: GRA outperforms 67.86% of its industry peers.
GRA has a Quick Ratio of 1.44. This is a normal value and indicates that GRA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.44, GRA is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.44
GRA.CA Yearly Current Assets VS Current LiabilitesGRA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2024 20M 40M 60M 80M

5

3. Growth

3.1 Past

GRA shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
Looking at the last year, GRA shows a quite strong growth in Revenue. The Revenue has grown by 9.12% in the last year.
GRA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.33% yearly.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)9.12%
Revenue growth 3Y24.8%
Revenue growth 5Y13.33%
Sales Q2Q%-10.1%

3.2 Future

GRA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.59% yearly.
GRA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.87% yearly.
EPS Next Y15.83%
EPS Next 2Y36.23%
EPS Next 3Y45.72%
EPS Next 5Y29.59%
Revenue Next Year9.38%
Revenue Next 2Y16.93%
Revenue Next 3Y25.67%
Revenue Next 5Y17.87%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GRA.CA Yearly Revenue VS EstimatesGRA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50M 100M 150M 200M 250M
GRA.CA Yearly EPS VS EstimatesGRA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.05 -0.05 -0.1

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GRA. In the last year negative earnings were reported.
Also next year GRA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GRA.CA Price Earnings VS Forward Price EarningsGRA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200

4.2 Price Multiples

GRA's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 100.68
GRA.CA Per share dataGRA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

GRA's earnings are expected to grow with 45.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.23%
EPS Next 3Y45.72%

0

5. Dividend

5.1 Amount

GRA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NANOXPLORE INC

TSX:GRA (7/4/2025, 7:00:00 PM)

2.355

-0.02 (-0.63%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)09-16 2025-09-16/amc
Inst Owners12.56%
Inst Owner ChangeN/A
Ins Owners7.38%
Ins Owner ChangeN/A
Market Cap401.79M
Analysts76
Price Target3.83 (62.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.99%
Min EPS beat(2)-53.98%
Max EPS beat(2)33.99%
EPS beat(4)2
Avg EPS beat(4)-8.63%
Min EPS beat(4)-53.98%
Max EPS beat(4)33.99%
EPS beat(8)4
Avg EPS beat(8)-15.47%
EPS beat(12)6
Avg EPS beat(12)-31.39%
EPS beat(16)7
Avg EPS beat(16)-61.64%
Revenue beat(2)0
Avg Revenue beat(2)-9.84%
Min Revenue beat(2)-14.65%
Max Revenue beat(2)-5.03%
Revenue beat(4)0
Avg Revenue beat(4)-6.39%
Min Revenue beat(4)-14.65%
Max Revenue beat(4)-1.56%
Revenue beat(8)1
Avg Revenue beat(8)-5.88%
Revenue beat(12)4
Avg Revenue beat(12)-2.77%
Revenue beat(16)5
Avg Revenue beat(16)-1.82%
PT rev (1m)-10.52%
PT rev (3m)-12.6%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-4.12%
Revenue NQ rev (3m)-17.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.97
P/FCF N/A
P/OCF 91.75
P/B 3.98
P/tB 4.62
EV/EBITDA 100.68
EPS(TTM)-0.06
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)0.03
OCFY1.09%
SpS0.79
BVpS0.59
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.48%
ROE -9.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.57%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y46.47%
GM growth 5Y4.81%
F-Score5
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA 3.63
Cap/Depr 108.56%
Cap/Sales 8.99%
Interest Coverage N/A
Cash Conversion 109.67%
Profit Quality N/A
Current Ratio 1.99
Quick Ratio 1.44
Altman-Z 5.05
F-Score5
WACC7.85%
ROIC/WACCN/A
Cap/Depr(3y)78.57%
Cap/Depr(5y)156.07%
Cap/Sales(3y)6.19%
Cap/Sales(5y)12.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y15.83%
EPS Next 2Y36.23%
EPS Next 3Y45.72%
EPS Next 5Y29.59%
Revenue 1Y (TTM)9.12%
Revenue growth 3Y24.8%
Revenue growth 5Y13.33%
Sales Q2Q%-10.1%
Revenue Next Year9.38%
Revenue Next 2Y16.93%
Revenue Next 3Y25.67%
Revenue Next 5Y17.87%
EBIT growth 1Y44.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year143.09%
EBIT Next 3Y68.1%
EBIT Next 5Y71.57%
FCF growth 1Y23.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y248.81%
OCF growth 3YN/A
OCF growth 5YN/A